Ottawa, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The global cell and gene therapy manufacturing market size was calculated at USD 21.15 billion in 2025 and is expected to reach around USD 215.18 billion by ...

Chicago, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The global stem cell manufacturing market was valued at US$ 24.26 billion in 2024 and is projected to reach US$ 65.49 billion by 2033, growing at a CAGR of ...

With cell manufacturing constrained, investments in storage systems are accelerating. Reliance Industries has put on hold plans to manufacture lithium-ion battery cells in India after failing to ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...

The Global Cell and Gene Therapy Manufacturing Market is valued at USD 12.58 Billion in 2024 and is projected to reach a value of USD 168.6 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of ...

As the CGT market evolves, developers must answer one key question that will shape their manufacturing strategy: “Should we go with a modular platform or a fully integrated system?”  Both approaches ...

Technology Adoption Program (TAP) program success demonstrates the ability of Cellares’ IDMO Smart Factory to automate, lower costs and scale out manufacturing for Cabaletta Bio’s clinical-stage CAR T ...

Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...

Despite the perception of biopharma as a field that is slow to adopt new technology, artificial intelligence (AI) has been quietly improving the sector for years, from candidate prioritization in drug ...